Remedy Revenue Slides as Control Resonant Marketing Ramps Up

Remedy Entertainment posted a 40% revenue decline in its second quarter as marketing spending for Control Resonant ramped up ahead of the sequel’s 24. September 2026 launch, the Finnish studio said in its half-year financial report released on 11. August 2026.

Revenue for April–Juni 2026 came in at €10.2 million, down from €16.9 million a year earlier, with an operating loss of €3.9 million against a €0.5 million loss in the same quarter of 2025. For the full first half, revenue fell 23.1% to €23.3 million, swinging Remedy from a €0.8 million operating profit in H1 2025 to a €2.9 million operating loss.

The year-ago comparison period is doing much of the work in those declines. Q2 2025 revenue included the launch of FBC: Firebreak, Remedy’s first self-published title, plus initial revenue accruals from subscription service agreements. Revenue from game sales and royalties in Q2 2026 totaled €3.8 million, down from €9.5 million in the comparison quarter, while development fees (originating from Control Resonant and the Max Payne 1&2 remake for Rockstar Games) were €6.4 million against €7.4 million a year earlier.

On the cost side, other operating expenses rose €1.7 million in the quarter to €4.4 million, which the report attributes directly to the Resonant marketing ramp. Personnel expenses were up 4.8% to €6.7 million, driven by general salary increases and additional efforts ahead of launch.

“Early signals and commercial metrics give us confidence in the game’s potential, but our focus remains on bringing an outstanding game to the market and letting the results speak,” CEO Jean-Charles Gaudechon wrote in the report. “I personally see the game getting stronger week by week and our marketing accelerates further in the third quarter.”

The Resonant Indicators Remedy Is Pointing At

The commercial markers Remedy disclosed alongside the numbers: Control Resonant has passed 1.5 million wishlists across platforms as of 11. August 2026. Pre-orders “opened with healthy momentum,” per the report, and the company’s PlayStation analytics show the game ranking among the top three pre-ordered titles in the US, Germany, and Brazil during the campaign window after the pre-order announcement.

Gaudechon, who was appointed CEO effective 1. März 2026, framed the release timing as deliberate. “In a competitive autumn window, we believe the distinctiveness and quality of the game will make it stand out,” he wrote, adding that the window has become “slightly less crowded” since the game’s original reveal. Remedy positions the sequel, its largest and most ambitious release to date, self-published under its own strategy, as a day-one purchase priced, in its words, attractively for an AAA title.

The Juni 2026 launch-date reveal at a PlayStation State of Play, followed by a second trailer at Summer Game Fest 2026, lifted the media embargo and produced the first hands-on previews. The shift to faster, melee-led action was the most debated element after announcement; per Gaudechon, it has since become one of the game’s most consistently acclaimed features in preview coverage.

By the Numbers

• Q2 2026 revenue: €10.2 million, down 40.0% (Q2 2025: €16.9 million)
• Q2 2026 operating result: -€3.9 million (Q2 2025: -€0.5 million)
• H1 2026 revenue: €23.3 million, down 23.1% (H1 2025: €30.3 million)
• H1 2026 operating result: -€2.9 million (H1 2025: +€0.8 million)
• Q2 game sales and royalties: €3.8 million (Q2 2025: €9.5 million)
• Q2 development fees: €6.4 million (Q2 2025: €7.4 million)
• Control Resonant wishlists: over 1.5 million as of 11. August 2026
• Cash and liquid investments: €29.6 million on 30. Juni 2026
• Headcount: 379 at period end, down 1.6% year over year

The Catalogue Carried the Quarter

The detail underneath the headline decline: the 2019 original Control grew its sales versus the comparison quarter, which the report credits to renewed interest driven by Resonant’s trailer reveals, release date, and live pre-orders. Remedy describes the original game as an important entry point into the franchise for new players: a dynamic tracked in our Control vs Control: Resonant comparison and our running Control: Resonant — Everything We Know coverage.

Alan Wake 2 passed three million lifetime copies during Q2, with royalties from it and Alan Wake Remastered generated entirely from consumer sales — no platform deal accruals in the period. Most of FBC: Firebreak‘s Q2 revenue, by contrast, consisted of accruals from subscription service agreements rather than new unit sales.

What the Report Says About the Rest of 2026

Remedy left its full-year outlook unchanged: it expects 2026 revenue and EBITDA to increase from 2025, a year in which it posted €59.5 million in revenue and a €14.9 million operating loss. That guidance now rests heavily on a single date. The company held €29.6 million in cash and liquid investments at the end of Juni 2026, with €15.6 million in convertible loan liabilities on the balance sheet from the financing agreement it entered with Tencent in September 2024.

The report also confirms the rest of the slate: the Max Payne 1&2 remake remains in full production with Rockstar Games as publisher, and an unannounced new project (self-published, like Resonant) has moved to production readiness. The next scheduled checkpoint is Remedy’s Q3 2026 business review on 3. November 2026, the first report that will capture Resonant’s opening weeks.